Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Establishment of functional and stable collaterals in the ischemic myocardium is crucial to restoring cardiac function after myocardial infarction. Here, we show that only dual delivery of a combination of angiogenic and arteriogenic factors to the ischemic myocardium could significantly reestablish stable collateral networks and improve myocardial perfusion and function. A combination of FGF-2 with PDGF-BB, two factors primarily targeting endothelial cells and vascular smooth muscle cells, remarkably promotes myocardial collateral growth and stabilizes the newly formed collateral networks, which significantly restore myocardial perfusion and function. Using various members of the PDGF family together with FGF-2 in an angiogenesis assay, we demonstrate that PDGFR-α is mainly involved in angiogenic synergism, whereas PDGFR-β mediates vessel stability signals. Our findings provide conceptual guidelines for the clinical development of proangiogenic/arteriogenic factors for the treatment of ischemic heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as well as to restore stable collateral networks and enhance myocardial perfusion and function in the infarcted myocardium [129]”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [129]
Citations
Cites
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C.-H., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,496
Ornitz, D. M., & Itoh, N. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews3005 · Cited by 2,272
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048
Hellström, M., Kalén, M., Lindahl, P., Abramsson, A., & Betsholtz, C. (1999) · Development · doi:10.1242/dev.126.14.3047 · Cited by 1,700
The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis
Henry, T. D., Annex, B. H., McKendall, G. R., Azrin, M. A., Lopez, J. J., Giordano, F. J., Shah, P. K., Willerson, J. T., Benza, R. L., Berman, D. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000061911.47710.8a · Cited by 1,025
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J. A., Fiddes, J. C., & Gospodarowicz, D. (1987) · Nature · doi:10.1038/325257a0 · Cited by 754
Cao, R., Bråkenhielm, E., Pawliuk, R., Wariaro, D., Post, M. J., Wahlberg, E., Leboulch, P., & Cao, Y. (2003) · Nature Medicine · doi:10.1038/nm848 · Cited by 721
Self-citationRosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.468 · Cited by 656
Simons, M., Annex, B. H., Laham, R. J., Kleiman, N., Henry, T., Dauerman, H., Udelson, J. E., Gervino, E. V., Pike, M., Whitehouse, M. J., et al. (2002) · Circulation · doi:10.1161/hc0802.104407 · Cited by 645
Schumacher, B., Pecher, P., von Specht, B. U., & Stegmann, T. (1998) · Circulation · doi:10.1161/01.cir.97.7.645 · Cited by 531
MAXWELL, M. P., HEARSE, D. J., & YELLON, D. M. (1987) · Cardiovascular Research · doi:10.1093/cvr/21.10.737 · Cited by 515
Signaling and Functions of Angiopoietin-1 in Vascular Protection
Brindle, N. P. J., Saharinen, P., & Alitalo, K. (2006) · Circulation Research · doi:10.1161/01.res.0000218275.54089.12 · Cited by 487
Discovery and development of anticancer aptamers
Ireson, C. R., & Kelland, L. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0172 · Cited by 481
Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus: An Expert Panel Summary
Simons, M., Bonow, R. O., Chronos, N. A., Cohen, D. J., Giordano, F. J., Hammond, H. K., Laham, R. J., Li, W., Pike, M., Sellke, F. W., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.e73 · Cited by 459
Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal
Khurana, R., Simons, M., Martin, J. F., & Zachary, I. C. (2005) · Circulation · doi:10.1161/circulationaha.105.535294 · Cited by 451
Coronary artery disease in the developing world
Okrainec, K., Banerjee, D. K., & Eisenberg, M. J. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.11.027 · Cited by 431
Signal transduction by fibroblast growth factor receptors
Klint, P. (1999) · Frontiers in Bioscience · doi:10.2741/klint · Cited by 424
Cohen, M., & Rentrop, K. P. (1986) · Circulation · doi:10.1161/01.cir.74.3.469 · Cited by 424
Angiogenesis: Where Do We Stand Now?
Simons, M. (2005) · Circulation · doi:10.1161/01.cir.0000159345.00591.8f · Cited by 411
Therapeutic Angiogenesis and Vasculogenesis for Ischemic Disease: Part I: Angiogenic Cytokines
Losordo, D. W., & Dimmeler, S. (2004) · Circulation · doi:10.1161/01.cir.0000128595.79378.fa · Cited by 357
Seiler, C., Pohl, T., Wustmann, K., Hutter, D., Nicolet, P.-A., Windecker, S., Eberli, F. R., & Meier, B. (2001) · Circulation · doi:10.1161/hc4201.097835 · Cited by 324
Angiogenesis in ischemic heart disease
Ware, J. A., & Simons, M. (1997) · Nature Medicine · doi:10.1038/nm0297-158 · Cited by 323
Hendel, R. C., Henry, T. D., Rocha-Singh, K., Isner, J. M., Kereiakes, D. J., Giordano, F. J., Simons, M., & Bonow, R. O. (2000) · Circulation · doi:10.1161/01.cir.101.2.118 · Cited by 295
Grines, C. L., Watkins, M. W., Mahmarian, J. J., Iskandrian, A. E., Rade, J. J., Marrott, P., Pratt, C., & Kleiman, N. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00988-4 · Cited by 289
Arteriogenesis The Development and Growth of Collateral Arteries
Helisch, A., & Schaper, W. K. A. (2003) · Microcirculation · doi:10.1038/sj.mn.7800173 · Cited by 279
Angiogenesis Therapy: Amidst the Hype, the Neglected Potential for Serious Side Effects
Epstein, S. E., Kornowski, R., Fuchs, S., & Dvorak, H. F. (2001) · Circulation · doi:10.1161/01.cir.104.1.115 · Cited by 233
Cao, R., Bråkenhielm, E., Li, X., Pietras, K., Widenfalk, J., Östman, A., Eriksson, U., & Cao, Y. (2002) · The FASEB Journal · doi:10.1096/fj.02-0319com · Cited by 229
Self-citationTherapeutic Angiogenesis With Basic Fibroblast Growth Factor: Technique and Early Results
Sellke, F. W., Laham, R. J., Edelman, E. R., Pearlman, J. D., & Simons, M. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00340-3 · Cited by 215
Li, X., Tjwa, M., Moons, L., Fons, P., Noel, A., Ny, A., Zhou, J. M., Lennartsson, J., Li, H., Luttun, A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci19189 · Cited by 172
Collateral Circulation of the Heart
Schaper, W., Piek, J. J., Munoz-Chapuli, R., Wolf, C., & Ito, W. (1999) · Angiogenesis And Cardiovascular Disease · doi:10.1093/oso/9780195112351.003.0008 · Cited by 171
Udelson, J. E., Dilsizian, V., Laham, R. J., Chronos, N., Vansant, J., Blais, M., Galt, J. R., Pike, M., Yoshizawa, C., & Simons, M. (2000) · Circulation · doi:10.1161/01.cir.102.14.1605 · Cited by 163
The Development of Collateral Circulation in the Pig and Dog Heart
Schaper, W. K. A., Jageneau, A. H. M., & Xhonneux, R. (2008) · Cardiologia · doi:10.1159/000165875 · Cited by 135
PDGF mediates cardiac microvascular communication.
Edelberg, J. M., Aird, W. C., Wu, W., Rayburn, H., Mamuya, W. S., Mercola, M., & Rosenberg, R. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3058 · Cited by 126
Fortuin, F. D., Vale, P. R., Losordo, D. W., Symes, J. F., DeLaria, G. A., Tyner, J., Schaer, G. L., MARCH, R. J., Snell, R. J., Henry, T. D., et al. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00661-1 · Cited by 117
Gyöngyösi, M., Khorsand, A., Zamini, S., Sperker, W., Strehblow, C., Kastrup, J., Jorgensen, E., Hesse, B., Tägil, K., Bøtker, H. E., et al. (2005) · Circulation · doi:10.1161/01.circulationaha.105.525782 · Cited by 114
Modulating Angiogenesis: More vs Less
Sivakumar, B., Harry, L. E., & Paleolog, E. M. (2004) · JAMA · doi:10.1001/jama.292.8.972 · Cited by 98
Growth factor-induced therapeutic angiogenesis in the heart: protein therapy
Annex, B. H., & Simons, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.004 · Cited by 92
Functional Importance of the Coronary Collaterals
Gregg, D. E., & Patterson, R. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198012113032406 · Cited by 89
Carmeliet, P., & Conway, E. M. (2001) · Nature Biotechnology · doi:10.1038/nbt1101-1019 · Cited by 79
Organization of Myocardial Activation During Ventricular Fibrillation After Myocardial Infarction
Thomas, S. P., Thiagalingam, A., Wallace, E., Kovoor, P., & Ross, D. L. (2005) · Circulation · doi:10.1161/circulationaha.104.503631 · Cited by 77
Encouraging Results for Second-Generation Antiangiogenesis Drugs
Marx, J. L. (2005) · Science · doi:10.1126/science.308.5726.1248 · Cited by 52
Ranibizumab: treatment in patients with neovascular age-related macular degeneration
Pieramici, D. J., & Avery, R. L. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.11.1237 · Cited by 44
The rational phase of therapeutic angiogenesis.
Mj, P., & Simons, M. (2003) · PubMed · Cited by 12
Effect of coronary artery reperfusion on infarct size in swine
Campbell, C., Takanashi, Y., Laas, J., Meus, P. J., Pick, R. L., & Replogle, R. L. (1981) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)37638-x · Cited by 9
Mechanisms of myocardial ischemia
Maseri, A. (1990) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00051288 · Cited by 7
Research works printed but not linked: 1
- MJ Post, M Simons Minerva Cardioangiol 51, 421–432 (2003).
Cited by
Targeting angiogenesis in oncology, ophthalmology and beyond
Cao, Y., Langer, R., & Ferrara, N. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00671-z · Cited by 315
Self-citationFibroblast growth factor regulation of neovascularization
Murakami, M., & Simons, M. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282f97d98 · Cited by 321
Dixon, J. A., & Spinale, F. G. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.814459 · Cited by 294
Ruvinov, E., Leor, J., & Cohen, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.097 · Cited by 278
“Multiple and/or sequential factor delivery had been described by other groups, applying different delivery systems or different combination of polymers [40,41].”
BackgroundAngiogenesis in the Infarcted Myocardium
Cochain, C., Channon, K. M., & Silvestre, J.-S. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4849 · Cited by 244
“As previously mentioned in this review, combined administration of an angiogenic and an arteriogenic growth factor, namely FGF-2 and PDGF-BB, synergistically enhances angiogenesis in the ischemic heart (70), but this concept is also relevant to cell-based therapy.”
Metadata
- Authors
- Lu, H., Xu, X., Zhang, M., Cao, R., Bråkenhielm, E., Li, C., Lin, H., Yao, G., Sun, H., Qi, L., Tang, M., Dai, H., Zhang, Y., Su, R., Bi, Y., Zhang, Y., & Cao, Y.
- Affiliations
- Ministry of Education of the People's Republic of China (CN)
- Karolinska Institutet (SE)
- *Key Laboratory of Cardiovascular Remodelling and Function Research, Chinese Ministry of Education and Public Health,
- Department of Cardiovascular Surgery, Qi Lu Hospital, Shandong University, Jinan 250012, Shandong Province, People's Republic of China; and
- Shandong University (CN)
- Corresponding author
- Zhang, Yun
- Cao, Yihai
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-07-17
- Volume
- 104
- Issue
- 29
- Pages
- 12140-12145
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1920536
- OpenAlex
- W2157040346
- Cited by
- 107
- References
- 48
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 1 · 2019: 5 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 5 · 2013: 11 · 2012: 7
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- myocardial ischemia, myocardial infarction, collateral vessel formation, angiogenesis, arteriogenesis, FGF2, PDGF-BB, PDGFRA, PDGFRβ, combination therapy, myocardial perfusion, cardiac function, vascular smooth muscle cells, endothelial cells, ischemic heart disease, pigs
- MeSH terms
- Becaplermin, Angiography, Animals, Collateral Circulation, Coronary Circulation, Drug Therapy, Combination, Echocardiography, Heart, Models, Biological, Platelet-Derived Growth Factor, Swine, Fibroblast Growth Factor 2, Myocardial Ischemia, Proto-Oncogene Proteins c-sis, Angiogenesis Inducing Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.